在亚托匹性皮肤炎中治疗到目标
Christian Vestergaard1, Catalina Skovsgaard2, Claus Johansen2
1Department of Dermatology, Aarhus University hospital, Aarhus, Denmark. christian.vestergaard@clin.au.dk.
American journal of clinical dermatology
|December 11, 2023
概括
针对阿托皮性皮肤炎 (AD) 的治疗目标策略需要纳入患者的并发症,以获得现实世界的成功. 结合经过验证的工具和电子报告,可以提高治疗效率和患者在治疗这种常见皮肤疾病的结果.
科学领域:
- 皮肤病学 皮肤病学
- 临床实践 临床实践
- 治疗策略 治疗策略
背景情况:
- 亚托邦性皮肤炎 (AD) 是一种普遍存在的炎症性皮肤疾病,影响儿童和成人.
- 最近的进展扩大了AD的治疗选择,包括局部和全身疗法.
- 在风湿病学中常见的治疗到目标方法,涉及在特定时间范围内设定明确的治疗目标.
研究的目的:
- 评估在现实临床实践中对亚托皮性皮肤炎的治疗目标策略的适用性.
- 探索用于测量治疗对伴随性疾病影响的验证工具的整合.
- 解决实施治疗到目标方法的挑战,例如数据收集时间.
主要方法:
- 基于对湿疹协调结果措施 (HOME) 倡议的建议,审查了针对亚托皮炎的现有治疗目标框架.
- 分析在当前框架中纳入并发症评估的情况.
- 讨论潜在的解决方案,包括患者报告结果的电子应用程序.
主要成果:
- 目前针对阿尔茨海默病的治疗目标框架主要依赖于湿疹区域和严重性指数 (EASI) 评分,以EASI-75作为共同的终点.
- 现有的框架往往缺乏工具来衡量治疗对患者共同疾病 (身体,心理,社会经济) 的影响.
- 为了实现治疗到目标的数据收集在临床环境中可能耗时.
结论:
- 针对阿托皮性皮炎的治疗目标策略需要适应现实世界的临床实践,强调以患者为中心的目标和共享决策.
- 整合验证的工具来评估并发症对于整体的治疗方法至关重要.
- 电子应用程序可以帮助减轻数据收集负担,促进处理到目标策略的实施.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Antiasthma Drugs: Leukotriene Modifiers
317
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
317
Hypersensitivities
673
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
673


